IRIDEX Reports Strong Preliminary Q4 & FY2025 Results, Achieves Positive Cash Flow and Adjusted EBITDA
IRIX sits 64% above its 52-week low of $0.782.
Summary
IRIDEX reported preliminary Q4 and full-year 2025 results, highlighting strong revenue growth, positive cash flow in Q4, and expected positive adjusted EBITDA for the full year, signaling improved financial health for the micro-cap company.
Key Events · Earnings and Guidance · IRIX
-
Strong Q4 Revenue Growth
Preliminary Q4 2025 revenue is expected to be between $14.6 million and $14.8 million, representing 15% to 17% year-over-year growth.
-
Positive Q4 Cash Flow Achieved
The company achieved positive cash flow in the fourth quarter of 2025, a significant financial milestone for a micro-cap entity.
-
Full Year Adjusted EBITDA Expected Positive
IRIDEX expects to achieve positive adjusted EBITDA for the full fiscal year 2025, indicating improved operational efficiency.
-
Consistent Revenue Growth
The company reported its fifth consecutive quarter of year-over-year revenue growth, demonstrating sustained business momentum.
Analysis · IRIX · Industrial Applications And Services
IRIDEX Corporation, a micro-cap company, announced preliminary financial results that indicate significant operational improvements and a strengthened financial position. Achieving positive cash flow in Q4 2025 and expecting positive adjusted EBITDA for the full year are critical milestones for a company of this size, addressing potential liquidity concerns and demonstrating a path to profitability. The consistent year-over-year revenue growth further underscores the company's operational momentum.
At the time of this filing, IRIX was trading at $1.28 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $20.5M. The 52-week trading range was $0.78 to $1.80. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.